Literature DB >> 16912925

Molecular cloning, stable expression and cellular localization of human alpha1-adrenergic receptor subtypes: effect of charcoal/dextran treated serum on expression and localization of alpha1D -adrenergic receptor.

Sunil K Khattar1, Roop Singh Bora, Priyanka Priyadarsiny, Aarti Gautam, Dikshi Gupta, Atul Tiwari, Kamna Nanda, Rahul Singh, Anita Chugh, Vinay Bansal, Kasim Mookhtiar, Kulvinder Singh Saini.   

Abstract

The cDNAs encoding for three subtypes of adrenergic receptors, alpha1A-, alpha1B- and alpha1D-ARs, were cloned and expressed in HEK 293 cells. Expression of alpha1A- and alpha1B-AR subtypes in HEK 293 cells was stable even with increased passages but that of alpha1D-AR was not. Cellular localization studies using immunofluorescence and flow cytometry revealed that expression of alpha1A- and alpha1B-ARs was primarily localized on the cell membrane whereas expression of alpha1D-AR was predominantly intracellular. Our studies clearly demonstrated that the culturing of the recombinant cell lines expressing alpha1D-AR in charcoal/dextran treated fetal bovine serum (FBS) resulted in targeting of alpha1D-AR to the cell membrane and thus, significantly improving its stability and availability for ligand binding studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912925     DOI: 10.1007/s10529-006-9148-x

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  2 in total

1.  The potential of metabolomic analysis techniques for the characterisation of α1-adrenergic receptors in cultured N1E-115 mouse neuroblastoma cells.

Authors:  Maria I Wenner; Garth L Maker; Linda F Dawson; Peter D Drummond; Ian Mullaney
Journal:  Cytotechnology       Date:  2015-09-25       Impact factor: 2.058

2.  Alpha(1D)-adrenergic receptor insensitivity is associated with alterations in its expression and distribution in cultured vascular myocytes.

Authors:  Lin-lin Fan; Shuang Ren; Hong Zhou; Ying Wang; Ping-xiang Xu; Jun-qi He; Da-li Luo
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.